The global pharmaceutical industry is faced with a growing counterfeit drugs market, a serious concern that is a strong deterrent to generic and innovative industries. Most importantly, it puts millions of lives at stake. According to the World Health Organization, roughly 50% of drugs consumed in developing nations are counterfeit. Among these, most are antibiotics and antimalarials. These drugs can harm patients and fail to treat the diseases they are treated for. Furthermore, they can hurt the reputation of the original product.
